Drugs / ANX776
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02394613 | May → Nov 2015 | glaucoma, ocular hypertension | University College, London | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ANX776 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02394613 ↗ |
| Modality | Diagnostic / imaging agent | “ANX776, as part of the new Detection of Apoptosing Retinal Cells (DARC) technique” NCT02394613 ↗ |
| Route | Intravenous | “Single intravenous injection” NCT02394613 ↗ |